Novel and unique diagnostic biomarkers for Bacillus anthracis infection

Applied and Environmental Microbiology

Volumn 75, Issue 19, 2009, Pages 6157-6167

  Sela Abramovich, Sagit ^b   Chitlaru, Theodor ^a   Gat, Orit ^a   Grosfeld, Haim ^a   Cohen, Ofer ^a   Shafferman, Avigdor ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b Life Science Research Israel   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACIS; BACILLUS ANTHRACIS; BLOOD CULTURE; DIRECT DETECTION; DNA VACCINATION; LIGAND AFFINITY; PERIPHERAL BLOOD; PLASMA SAMPLES; PRE-SELECTED; PROTECTIVE ANTIGENS; SECRETED PROTEIN; SECRETOME; SERUM PROTEINS; SRC HOMOLOGY 3; THURINGIENSIS;

ANTIGENS; BACTERIA; BACTERIOLOGY; BLOOD; CHROMATOGRAPHIC ANALYSIS; COLUMN CHROMATOGRAPHY; NUCLEIC ACIDS; PROTEINS;

ANIMALS;

BACTERIAL ANTIGEN; BIOLOGICAL MARKER; HTRA PROTEASE; PLASMA PROTEIN; PROTEIN P60; PROTEIN SH3; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL; ANTIGEN; BIOMARKER; BLOOD; DNA; ENZYME ACTIVITY; INFECTIOUS DISEASE; MAMMAL; MICROBIAL ACTIVITY; PATHOGENICITY; PLASMA; PROTEIN; REMOVAL EXPERIMENT; VACCINATION;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS THURINGIENSIS; BACTEREMIA; BACTERIUM DETECTION; BLOOD CULTURE; BLOOD SAMPLING; CHROMATOGRAPHY; COLONY FORMING UNIT; CONTROLLED STUDY; DNA IMMUNIZATION; GENOMICS; INOCULATION; NONHUMAN; PROTEIN ANALYSIS; PROTEOMICS; RABBIT; WESTERN BLOTTING;

ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS THURINGIENSIS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOLOGICAL MARKERS; ENDOPEPTIDASES; PLASMA; RABBITS; SERINE ENDOPEPTIDASES;

ANIMALIA; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS THURINGIENSIS; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS;

EID: 70349410319     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00766-09     Document Type: Article

References (88)

1. Ahmed, N., G. Barker, K. Oliva, D. Garfin, K. Talmadge, H. Georgiou, M. Quinn, and G. Rice. 2003. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics 3:1980-1987. (Pubitemid 37305892)
2. Altboum, Z., Y. Gozes, A. Barnea, A. Pass, M. White, and D. Kobiler. 2002. Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs. Infect. Immun. 70:6231-6241.
3. Anantharaman, V., and L. Aravind. 2003. Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol. 4:RII.
4. Antelmann, H., R. C. Williams, M. Miethke, A. Wipat, D. Albrecht, C. R. Harwood, and M. Hecker. 2005. The extracellular and cytoplasmic proteomes of the non-virulent Bacillus anthracis strain UM23C1-2. Proteomics 5:3684-3695.
5. Ariel, N., A. Zvi, H. Grosfeld, O. Gat, Y. Inbar, B. Velan, S. Cohen, and A. Shafferman. 2002. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1 - in silico and in vitro screening. Infect. Immun. 7:6817-6827.
6. Ariel, N., A. Zvi, K. Makarova, T. Chitlaru, E. Elhanany, B. Velan, S. Cohen, A. Friedlander, and A. Shafferman. 2003. Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect. Immun. 71:4563-4579.
7. Aronson, A. I., C. Bell, and B. Fulroth. 2005. Plasmid-encoded regulator of extracellular proteases in Bacillus anthracis. J. Bacteriol. 187:3133-3138.
8. Baillie, L., and T. D. Read. 2001. Bacillus anthracis, a bug with attitude. Curr. Opin. Microbiol. 4:78-81.
9. Björhall, K., T. Miliotis, and P. Davidsson. 2005. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5:307-317. (Pubitemid 40189661)
10. Blendon, R. J., J. M. Benson, C. M. Des Roches, W. E. Pollard, C. Parvanta, and M. J. Herrmann. 2002. The impact of anthrax attacks on the American public. Med. Gen. Med. 4:1.
11. Blue, S. R., V. R. Singh, and M. A. Saubolle. 1995. Bacillus licheniformis bacteremia: five cases associated with indwelling central venous catheters. Clin. Infect. Dis. 20:629-633.
12. Boschetti, E., L. Lomas, A. Citterio, and P. G. Righetti. 2007. Romancing the "hidden proteome," anno domini two zero zero seven. J. Chromatogr. A 1153:277-290.
13. Boschetti, E., and P. G. Righetti. 2008. The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species. J. Proteomics 71:255-264.
14. Bradley, K., J. Mogridge, M. Mourez, B. Collier, and J. Young. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-229. (Pubitemid 33051239)
15. Brossier, F., M. Levy, and M. Mock. 2002. Anthrax spores make an essential contribution to vaccine efficacy. Infect. Immun. 70:661-664.
16. Broussard, L. A. 2001. Biological agents: weapons of warfare and bioterrorism. Mol. Diagn. 6:323-333.
17. Bryskier, A. 2002. Bacillus anthracis and antibacterial agents. Clin. Microbiol. Infect. 8:467-478.
18. Cendrowski, S., W. MacArthur, and P. Hanna. 2004. Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence. Mol. Microbiol. 551:407-417.
19. Chensue, S. W. 2003. Exposing a killer: pathologists angle for anthrax. Am. J. Pathol. 163:1699-1702.
20. Chitlaru, T., N. Ariel, A. Zvi, M. Lion, B. Velan, A. Shafferman, and E. Elhanany. 2004. Identification of chromosomally encoded membranal polypeptides of Bacillus anthracis by a proteomic analysis: prevalence of proteins containing S-layer homology domains. Proteomics 4:677-691.
21. 2-dependent cross-talk mechanisms modulate extracellular proteolytic activities. J. Bacteriol. 188:3551-3571.
22. Chitlaru, T., O. Gat, Y. Gozlan, H. Grosfeld, I. Inbar, and A. Shafferman. 2007. Identification of in vivo expressed immunogenic proteins by serological proteome analysis of Bacillus anthracis secretome. Infect. Immun. 75:2841-2852.
23. Chung, M. C., T. G. Popova, B. A. Millis, D. V. Mukherjee, W. Zhou, L. A. Liotta, E. F. Petricoin, V. Chanhoke, C. Bailey, and S. G. Popov. 2006. Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. J. Biol. Chem. 281:31408-31418.
24. Cohen, S., I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany, T. Bino, M. Leitner, I. Inbar, H. Rosenberg, Y. Gozes, R. Barak, M. Fisher, C. Kronman, B. Velan, and A. Shafferman. 2000. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 68:4549-4558.
25. Delvecchio, V. G., J. P. Connolly, T. G. Alefantis, A. Walz, M. A. Quan, G. Patra, J. M. Ashton, J. T. Whittington, R. D. Chafin, X. Liang, P. Grewal, A. S. Khan, and C. V. Mujer. 2006. Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus and Bacillus thuringiensis. Appl. Environ. Microbiol. 72:6355-6363.
26. Dinges, M., P. Orwin, and P. Schlievert. 2000. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 13:16-36.
27. Dixon, T. C., M. Meselson, T. Guillemin, and P. Hanna. 1999. Anthrax. N. Engl. J. Med. 341:815-826.
28. Drobniewski, F. A. 1993. Bacillus cereus and related species. Clin. Microbiol. Rev. 6:324-338.
29. Echan, L. A., H.-Y. Tang, N. Ali-Khan, K. Lee, and D. W. Speicher. 2005. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 5:3292-3303.
30. Edwards, K. A., H. A. Clancy, and A. J. Baeumner. 2006. Bacillus anthracis: toxicology, epidemiology and current rapid-detection methods. Anal. Bioanal. Chem. 384:73-84.
31. Fellows, P. F., M. K. Linscott, B. E. Ivins, M. L. M. Pitt, C. A. Rossi, P. H. Gibbs, and A. M. Friedlander. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241-3247.
32. Fisher, N., L. Shetron-Rama, A. Herring-Palmer, B. Heffernan, N. Bergman, and P. Hanna. 2006. The dltABCD operon of Bacillus anthracis Sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity. J. Bacteriol. 188:1301-1309.
33. Francis, A. W., C. E. Ruggiero, A. T. Koppisch, J. Dong, J. Song, T. Brettin, and S. Iyer. 2005. Proteomic analysis of Bacillus anthracis Sterne vegetative cells. Biochim. Biophys. Acta 1748:191-200.
34. Frazier, A. A., T. Franks, and J. Galvin. 2006. Inhalational anthrax. J. Thorac. Imaging 21:252-258.
35. Friedlander, A., S. Welkos, and B. Ivins. 2002. Anthrax vaccines. Curr. Top. Microbiol. Immunol. 271:34-60.
36. Gat, O., I. Inbar, R. Aloni-Gristein, E. Zahavy, C. Kronman, I. Mendelson, S. Cohen, B. Velan, and A. Shafferman. 2003. Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines. Infect. Immun. 71:801-813.
37. Gat, O., I. Mendelson, T. Chitlaru, N. Ariel, Z. Altboum, H. Levy, S. Weiss, H. Grosfeld, S. Cohen, and A. Shafferman. 2005. The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant. Mol. Microbiol. 58:533-551.
38. Gat, O., H. Grosfeld, N. Ariel, I. Inbar, G. Zaide, Y. Broder, A. Zvi, T. Chitlaru, Z. Altboum, D. Stein, S. Cohen, and A. Shafferman. 2006. Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen. Infect. Immun. 74:3987-4001.
39. Gat, O., H. Grosfeld, and A. Shafferman. 2007. In vitro screen of bioinformatically selected Bacillus anthracis vaccine candidates by coupled transcription, translation and immunoprecipitation analysis. Methods Mol. Biol. 375:211-233.
40. Gat, O., G. Zaide, I. Inbar, H. Grosfeld, T. Chitlaru, H. Levy, and A. Shafferman. 2008. Characterization of Bacillus anthracis iron-regulated surface determinant (Isd) proteins containing NEAT domains. Mol. Microbiol. 70:983-999.
41. Gohar, M., O. A. Okstad, N. Gilois, V. Sanchis, A.-B. Kolsto, and D. Lereclus. 2002. Two-dimensional electrophoresis analysis of the extracellular proteome of Bacillus cereus reveals the importance of the PlcR regulon. Proteomics 2:784-791.
42. Gohar, M., N. Gilois, R. Graveline, C. Garreau, V. Sanchis, and D. Lereclus. 2005. A comparative study of B. cereus, B. thuringiensis and B. anthracis extracellular proteomes. Proteomics 5:3696-3711.
43. Gohar, M., K. Faegri, S. Perchat, S. Ravnum, O. A. Økstad, M. Gominet, A.-B. Kolstø, and D. Lereclus. 2008. The PlcR virulence regulon of Bacillus cereus. PLoS ONE 3:e2793.
44. Govorukhina, N. I., A. Keizer-Gunnink, A. G. van der Zee, S. de Jong, H. W. Bruijn, and R. Bischoff. 2003. Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion. J. Chromatogr. A 1009:171-178.
45. Grosfeld, H., S. Cohen, T. Bino, Y. Flashner, R. Bar, E. Mamroud, C. Kronman, A. Shafferman, and B. Velan. 2003. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigens. Infect. Immun. 71:374-383.
46. Heffernan, B., B. Thomason, A. Herring-Palmer, L. Shaughnessy, R. McDonald, N. Fisher, G. Huffnagle, and P. Hanna. 2006. Bacillus anthracis phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax. Infect. Immun. 74:3756-3764.
47. Heine, H. S., J. Bassett, L. Miller, J. M. Hartings, B. E. Ivins, M. L. Pitt., D. Fritz, S. L. Norris, and W. R. Byrne. 2007. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model. Antimicrob. Agents Chemother. 51:1373-1379.
48. Heine, H. S., J. Bassett, L. Miller, A. Bassett, B. E. Ivins, D. Lehoux, F. F. Arhin, T. R. Parr, Jr., and G. Moeck. 2008. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax. Antimicrob. Agents Chemother. 52:3350-3357.
49. Helgason, E., O. A. Økstad, D. A. Caugant, H. A. Johansen, A. Fouet, M. Mock, I. Hegna, and A.-B. Kolstø. 2000. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis - one species on the basis of genetic evidence. Appl. Environ. Microbiol. 66:2627-2630.
50. Hoffmaster, A. R., J. Ravel, D. A. Rasko, G. D. Chapman, M. D. Chute, C. K. Marston, B. K. De, C. T. Sacchi, C. Fitzgerald, L. W. Mayer, M. C. Maiden, F. G. Priest, M. Barker, L. Jiang, R. Z. Cer, J. Rilstone, S. N. Peterson, R. S. Weyant, D. R. Galloway, T. T. Read, T. Popovic, and C. M. Fraser. 2004. Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc. Natl. Acad. Sci. USA 101:8449-8454.
51. Issaq, H., Z. Xiao, and T. D. Veenstra. 2007. Serum and plasma proteins. Chem. Rev. 107:3601-3620.
52. Klimpel, K. R., N. Arora, and S. H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
53. Kobiler, D., S. Weiss, H. Levy, M. Fisher, A. Mechaly, A. Pass, and Z. Altboum. 2006. Protective antigen as a correlative marker for anthrax in animal models. Infect. Immun. 74:5871-5876.
54. Lacy, T. M., and R. J. Collier. 2002. Structure and function of anthrax toxin. Curr. Top. Microbiol. Immunol. 271:62-85.
55. Leppla, S. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79:3162-3166.
56. Leppla, S. H. 1995. Anthrax toxins, p. 543-572. In J. Moss, B. Iglewski, M. Vaughan, and A. T. Tu (ed.), Bacterial toxins and virulence factors in disease. Marcel Dekker, New York, NY.
57. Leppla, S. 1999. The bifactorial B. anthracis lethal and oedema toxins, p. 243-263. In J. E. Alouf and J. H. Freer (ed.), Comprehensive sourcebook of bacterial protein toxins. Academic Press, London, United Kingdom.
58. Marino, M., M. Banerjee, R. Jonquieres, P. Cossart, and P. Ghosh. 2002. GW domains of the Listeria monocytogenes invasion protein InlB are SH3-like and mediate binding to host ligands. EMBO J. 21:5623-5634.
59. Matsumoto, S., H. Suenaga, K. Naito, M. Sawazaki, T. Hiramatsu, and N. Agata. 2000. Management of suspected nosocomial infection: an audit of 19 hospitalized patients with septicemia caused by Bacillus species. Jpn. J. Infect. Dis. 53:196-202. (Pubitemid 32140742)
60. Mendelson, I., O. Gat, R. Aloni-Grinstein, Z. Altboum, I. Inbar, C. Kronman, E. Bar-Haim, S. Cohen, B. Velan, and A. Shafferman. 2005. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Vaccine 23:5688-5697.
61. Miyoshi, S., and S. Shinoda. 2000. Microbial metalloproteases in pathogenesis. Microbes Infect. 2:91-98.
62. Mock, M., and A. Fouet. 2001. Anthrax. Annu. Rev. Microbiol. 55:647-671.
63. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
64. Novick, R. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:1429-1449.
65. Omenn, G. S., and the HUPO Plasma Proteome Project Consortium. 2005. Overview of the HUPO plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and publicly-available database. Proteomics 5:3227-3245.
66. Passalacqua, K. D., N. H. Bergman, A. Herring-Palmer, and P. Hanna. 2006. The superoxide dismutases of Bacillus anthracis do not cooperatively protect against endogenous superoxide stress. J. Bacteriol. 188:3837-3848.
67. Pezard, C., M. Weber, J.-C. Sirard, P. Berche, and M. Mock. 1995. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect. Immunol. 63:1369-1372.
68. Ramarao, N., and D. Lereclus. 2005. The InhA1 metalloprotease allows spores of the B. cereus group to escape macrophages. Cell. Microbiol. 7:1357-1364.
69. Read, T. D., S. N. Peterson, N. Tourasse, L. W. Baillie, I. T. Paulsen, K. E. Nelson, H. Tettelin, D. E. Fouts, J. A. Eisen, S. R. Gill, E. K. Holtzapple, O. A. Okstad, E. Helgason, J. Rilstone, M. Wu, J. F. Kolonay, M. J. Beanan, R. J. Dodson, L. M. Brinkac, M. Gwinn, R. T. DeBoy, R. Madpu, S. C. Daugherty, A. S. Durkin, D. H. Haft, W. C. Nelson, J. D. Peterson, M. Pop, H. M. Khouri, D. Radune, J. L. Benton, Y. Mahamoud, L. Jiang, I. R. Hance, J. F. Weidman, K. J. Berry, R. D. Plaut, A. M. Wolf, K. L. Watkins, W. C. Nierman, A. Hazen, R. Cline, C. Redmond, J. E. Thwaite, O. White, S. L. Salzberg, B. Thomason, A. M. Friedlander, T. M. Koehler, P. C. Hanna, A. B. Kolsto, and C. M. Fraser. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423:81-86.
70. Reuveny, S., M. White, Y. Adar, Y. Kafri, Z. Altboum, Y. Gozes, D. Kobiler, A. Shafferman, and B. Velan. 2002. Search for correlates of protective immunity conferred by anthrax vaccine. Infect. Immun. 69:2888-2893.
71. Ross, C., and T. Koehler. 2006. plcR papR-independent expression of anthrolysin O by Bacillus anthracis. J. Bacteriol. 188:7823-7829.
72. Rossi, C. A., M. Ulrich, S. Norris, D. S. Reed, L. M. Pitt, and E. K. Leffel. 2008. Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax. Infect. Immun. 76:5790-5801.
73. Rowe, C., S. Scruggs, M. Feldstein, J. Golden, and F. Ligler. 1999. An array immunosensor for simultaneous detection of clinical analytes. Anal. Chem. 75:433-439.
74. Shafazand, S., R. Doyle, S. Ruoss, A. Weinacker, and T. Raffin. 1999. Inhalation anthrax: epidemiology, diagnosis and management. Chest 116:1369-1376. (Pubitemid 29535995)
75. Singh, Y., K. Klimpel, S. Goel, P. Swain, and S. Leppla. 1999. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect. Immun. 67:1853-1859.
76. Splettstoesser, W., L. Rahalison, R. Grunow, H. Neubauer, and S. Chanteau. 2004. Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague. FEMS Immunol. Med. Microbiol. 41:149-155.
77. Stern, E. J., K. B. Uhde, S. V. Shadomy, and N. Messonnier. 2008. Conference report on public health and clinical guidelines for anthrax. Emerg. Infect. Dis. 14:07-0969.
78. Tjalsma, H., H. Antelmann, J. D. H. Jongbloed, P. G. Braun, E. Darmon, R. Dorenbos, J.-Y. F. Dubois, H. Westers, G. Zanen, W. J. Quax, O. P. Kuipers, S. Bron, M. Hecker, and J. M. van Dijl. 2004. Proteomics of protein secretion by Bacillus subtilis: separating the "secrets" of the secretome. Microbiol. Mol. Biol. Rev. 68:207-233.
79. Turnbull, P. C. B. 1999. Definitive identification of Bacillus anthracis - a review. J. Appl. Microbiol. 87:237-240.
80. Voigt, B., T. Schweder, D. Becher, A. Ehrenreich, G. Gottschalk, J. Feesche, K.-H. Maurer, and M. Hecker. 2004. A proteomic view of cell physiology of Bacillus licheniformis. Proteomics 4:1465-1490.
81. Voigt, B., T. Schweder, M. J. J. Sibbald, D. Albrecht, A. Ehrenreich, J. J. Bernhardt, J. Feesche, K.-H. Maurer, G. Gottschalk, J. M. Van Dijl, and M. Hecker. 2005. The extracellular proteome of Bacillus licheniformis grown in different media under different nutrient starvation conditions. Proteomics 6:268-281.
82. Voigt, B., H. Antelman, D. Albrecht, A. Ehrenreich, K.-H. Maurer, S. Evers, G. Gottschalk, J. M. van Dijl, T. Schweder, and M. Hecker. 2009. Cell physiology and protein secretion of Bacillus licheniformis compared to Bacillus subtillis. J. Mol. Microbiol. Biotechnol. 16:53-68.
83. Wang, Y. Y., P. Cheng, and D. W. Chan. 2003. A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis. Proteomics 3:243-248.
84. Wilson, A. C., M. Soyer, J. A. Hoch, and M. Perego. 2008. The bicarbonate transporter is essential for Bacillus anthracis lethality. PLoS Pathog. 4:e1000210.
85. Wright, G., M. Puzzis, and B. Neely. 1962. Studies on immunity in anthrax. J. Bacteriol. 83:515-522.
86. Wu, H.-J., A. H.-J. Wang, and M. Jennings. 2008. Discovery of virulence factors of pathogenic bacteria. Curr. Opin. Chem. Biol. 12:93-101.
87. Wylie, G. P., V. Ranghachari, E. A. Bienkiewicz, V. Marin, N. Bhattacharya, J. F. Love, J. R. Murphy, and T. M. Logan. 2005. Prolylpeptide binding by the prokaryotic SH3-like domain of the diphtheria toxin repressor: a regulatory switch. Biochemistry 44:40-51.
88. Zwick, M. E., M. P. Kiley, A. C. Stewart, A. Mateczun, and T. D. Read. 2008. Genotyping of Bacillus cereus strains by microarray-based resequencing. 2008. PLoS ONE 3:e2513.